Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

NEO-CORTEF

HYDROCORTISONE ACETATE; NEOMYCIN SULFATE

Standard Dose
0.5%;EQ 3.5MG BASE/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-CORTEF is listed in Drugs@FDA under application 060751 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE; NEOMYCIN SULFATE Form and strength OINTMENT;TOPICAL - 0.5%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEO-CORTEF is listed in Drugs@FDA under application 060751 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE; NEOMYCIN SULFATE Form and strength OINTMENT;TOPICAL - 0.5%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NEO-CORTEF (HYDROCORTISONE ACETATE; NEOMYCIN SULFATE) | Drug Monograph | MedicHelpline